ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · Real-Time Price · USD
0.1470
-0.0376 (-20.37%)
Jul 18, 2025, 4:00 PM EDT - Market closed
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $716.40 thousand as of July 18, 2025. Its market cap has decreased by -77.18% in one year.
Market Cap
716.40K
Enterprise Value
-94.42K
1-Year Change
-77.18%
Ranking
Category
Stock Price
$0.15
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from $160.33M to $716.40K, a decrease of -99.55%. That is a compound annual growth rate of -79.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2025 | 967.19K | -70.63% |
| Dec 31, 2024 | 3.29M | -9.69% |
| Dec 29, 2023 | 3.65M | -74.40% |
| Dec 30, 2022 | 14.24M | -91.12% |
View and export this data all the way back to 2022. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.83B |
| Johnson & Johnson | 373.35B |
| AbbVie | 329.24B |
| Novo Nordisk | 299.09B |
| UnitedHealth Group | 264.62B |
| Novartis AG | 234.87B |
| Abbott Laboratories | 228.77B |
| AstraZeneca | 217.99B |